Skip to main content

Osteoporosis, Sports Medicine

Julie M. Kerr, MD, CAQSM Reviewed 04/2019
 


BASICS

DESCRIPTION

  • Systemic disorder characterized by decreased bone mass and microarchitectural deterioration of bone leading to bone fragility and increased susceptibility to fractures of the hip, sp...

DIAGNOSIS

HISTORY

  • General risk factor assessment

  • Low trauma fracture at age 50 yr and above

  • Historical height loss: peak height age 20—current height ≥4 cm

  • Prospective height loss: previously documented h...

TREATMENT

Osteoporosis treatment reduces fracture risk and is recommended by the National Osteoporosis Foundation (NOF) for women and men with a personal history of a hip or vertebral fracture, a T-sc...

ONGOING CARE

FOLLOW-UP RECOMMENDATIONS

Patient Monitoring

  • Changes in BMD levels indicative of real biologic change can be measured after 1 yr of treatment with serial DEXA.

  • Repeat BMD assessments every 2...

REFERENCES

1
Cosman F, de Beur SJ, LeBoff MS, et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int.  2014;25(10):2359–2381.
2
Duque G, Daly R, Sanders K, et al. Vitam...

ADDITIONAL READING

  • Binkley N, Carter GD. Toward clarity in clinical vitamin D status assessment: 25(OH)D assay standardization. Endocrinol Metab Clin North Am.  2017;46(4):885–899.

  • Harsløf T, Lang...

CLINICAL PEARLS

  • United States Preventive Services Task Force (USPSTF) recommends DEXA screening for women 65 yr and older.

  • USPSTF recommends screening for postmenopausal women <65 yr at increased ri...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

×